Topics

TOPICS

ANEMIA

LCL161 Shows Moderately Positive Objective Response Rate in Patients With Myelofibrosis

Novel Strategies May Help Reduce Required Red Cell Units in Transfusion for Patients With Sickle Cell Disease

BLEEDING DISORDERS

Standardized Ultrasound Guidelines Needed for Patients With Hemophilia, According to Expert Panel

Aerobic, Resistance, Combined Training Improves Lipid Profiles and Quality of Life in Overweight Patients With Hemophilia A

GENERAL HEMATOLOGY

COVID-19: What Do We Know About Outcomes in Hematologic Malignancies?

ACE2-Lowering Antineoplastics May Reduce Risk of SARS-CoV-2 in Cancer Patients

LEUKEMIA

CD200 Overexpression in Acute Myeloid Leukemia: A Potential Target

Antibody Responses After COVID-19 Vaccination in Patients With Chronic Lymphocytic Leukemia

LYMPHOMA

Combination Temsirolimus and Lenalidomide Seems Feasible in Relapsed/Refractory Lymphomas

Rituximab Biosimilars Produce Comparable Outcomes in Diffuse Large B-Cell Lymphoma

MYELODYSPLASTIC SYNDROMES

Myeloproliferative Neoplasms: How Do MPNs Affect Quality of Life?

Possible Response Biomarkers Identified in Non-Del(5q) Lower-Risk Myelodysplastic Syndrome

MYELOMA

Prognostic Importance of Extramedullary Lesions in Multiple Myeloma

Dosing Schedule of Intravenous Bisphosphonate Has Little Effect on Recurrent Skeletal-Related Events in Patients With Multiple Myeloma

SIDE EFFECT MANAGEMENT

ONS Releases Guidelines on the Management of Cancer Treatment–Related Hot Flashes

New NCCN Patient Guidelines Feature Immunotherapy, CAR-T Side Effects

THALASSEMIAS

Patients With Beta-Thalassemia Receiving Therapy May Suffer From Growth Issues

Economics of Betibeglogene Autotemcel for Patients With Transfusion-Dependent Beta-Thalassemia

THROMBOTIC DISORDERS

ASH Suggests Not Using Outpatient Thromboprophylaxis for COVID-19

Prothrombic Immune Thrombocytopenia in Patients Following ChAdOx1 Vaccine

Next post in General Hematology

ACE2-Lowering Antineoplastics May Reduce Risk of SARS-CoV-2 in Cancer Patients